Methods of treating eosinophilic esophagitis
US12059494B2 · kind B2 · utility
2Cited by
45References
36Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 11, 2023 |
| Grant date | Aug 13, 2024 |
| Priority date | — |
| Expiry date | Sep 11, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides methods of treating inflammation of the upper gastrointestinal tract, especially the esophagus, by administering an oral corticosteroid. In some cases, the methods include treating eosinophilic esophagitis (EoE) by administering an oral corticosteroid in an induction phase and a maintenance phase to improve peak eosinophilic counts and symptoms. In embodiments, the methods include treating EoE by administering the oral corticosteroid at nighttime and/or while the patient is lying down.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.